Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
BofA makes 14 additions, four deletions from US 1 list » 07:33
07/01/20
07/01
07:33
07/01/20
07:33
HLT

Hilton

$73.44 /

-0.42 (-0.57%)

, LB

L Brands

$15.00 /

-0.12 (-0.79%)

, STZ

Constellation Brands

$174.43 /

+0.46 (+0.26%)

, ACGL

Arch Capital

$28.68 /

+0.31 (+1.09%)

, C

Citi

$51.10 /

+0.79 (+1.57%)

, HRC

Hill-Rom

$109.92 /

+1.71 (+1.58%)

, UNP

Union Pacific

$169.21 /

+3.73 (+2.25%)

, SPLK

Splunk

$198.64 /

+4.26 (+2.19%)

, QCOM

Qualcomm

$91.21 /

+2.1 (+2.36%)

, IMMU

Immunomedics

$35.45 /

+1.205 (+3.52%)

, NFLX

Netflix

$454.96 /

+7.86 (+1.76%)

, CHTR

Charter

$509.92 /

+1.43 (+0.28%)

, ATVI

Activision Blizzard

$75.89 /

+0.43 (+0.57%)

, EQIX

Equinix

$701.53 /

+14.1 (+2.05%)

, FANG

Diamondback Energy

$41.82 /

+0.38 (+0.92%)

, ALSN

Allison Transmission

$36.78 /

-0.055 (-0.15%)

, MDLZ

Mondelez

$51.12 /

+0.53 (+1.05%)

, SMG

Scotts Miracle-Gro

$134.50 /

+4.66 (+3.59%)

BofA added the following…

BofA added the following names to the US 1 List: Hilton (HLT), L Brands (LB) Constellation Brands (STZ), Arch Capital (ACGL), Citi (C), Hill-Rom (HRC), Union Pacific (UNP), Splunk (SPLK), Qualcomm (QCOM), Immunomedics (IMMU), Netflix (NFLX), Charter (CHTR), Activision Blizzard (ATVI) and Equinix (EQIX). The firm removed Diamondback Energy (FANG), Allison Transmission (ALSN), Mondelez (MDLZ) and Scotts Miracle-Gro (SMG). The firm's US 1 list is intended to represent a collection of best investment ideas among Buy-rated, U.S.-listed stocks that fundamental equity research analysts at BofA cover.

ShowHide Related Items >><<
UNP Union Pacific
$169.21 /

+3.73 (+2.25%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SPLK Splunk
$198.64 /

+4.26 (+2.19%)

SMG Scotts Miracle-Gro
$134.50 /

+4.66 (+3.59%)

QCOM Qualcomm
$91.21 /

+2.1 (+2.36%)

NFLX Netflix
$454.96 /

+7.86 (+1.76%)

MDLZ Mondelez
$51.12 /

+0.53 (+1.05%)

LB L Brands
$15.00 /

-0.12 (-0.79%)

IMMU Immunomedics
$35.45 /

+1.205 (+3.52%)

HRC Hill-Rom
$109.92 /

+1.71 (+1.58%)

HLT Hilton
$73.44 /

-0.42 (-0.57%)

FANG Diamondback Energy
$41.82 /

+0.38 (+0.92%)

EQIX Equinix
$701.53 /

+14.1 (+2.05%)

CHTR Charter
$509.92 /

+1.43 (+0.28%)

C Citi
$51.10 /

+0.79 (+1.57%)

ATVI Activision Blizzard
$75.89 /

+0.43 (+0.57%)

ALSN Allison Transmission
$36.78 /

-0.055 (-0.15%)

ACGL Arch Capital
$28.68 /

+0.31 (+1.09%)

HLT Hilton
$73.44 /

-0.42 (-0.57%)

06/25/20 Gordon Haskett
Hilton initiated with a Hold at Gordon Haskett
06/23/20 Nomura Instinet
Hilton price target raised to $121 from $102 at Nomura Instinet
06/22/20 Barclays
Barclays turns positive on lodging, upgrades Hilton to Overweight
06/22/20 Barclays
Barclays upgrades DiamondRock on 'drive-to' resort exposure
LB L Brands
$15.00 /

-0.12 (-0.79%)

06/04/20 UBS
American Eagle price target raised to $15 from $10.90 at UBS
06/03/20 Jefferies
Jefferies raises price target on 'leader of the pack' American Eagle to $14
05/29/20 Goldman Sachs
Goldman ups L Brands target to $20 on 'compelling' value unlock story
05/22/20 Barclays
L Brands price target raised to $17 from $10 at Barclays
STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

06/17/20 JPMorgan
Constellation Brands added to Analyst Focus List at JPMorgan
06/01/20 Cowen
Constellation Brands price target raised to $205 from $160 at Cowen
05/20/20 MKM Partners
MKM Partners sees negative pre-announcement as likely from Constellation Brands
05/08/20
Fly Intel: Top five analyst downgrades
ACGL Arch Capital
$28.68 /

+0.31 (+1.09%)

05/22/20 BofA
Arch Capital resumed with a Buy at BofA
05/06/20 Wells Fargo
Arch Capital price target lowered to $34 from $40 at Wells Fargo
04/08/20 RBC Capital
Arch Capital price target lowered to $40 from $53 at RBC Capital
04/01/20 Wells Fargo
Arch Capital price target lowered to $40 from $52 at Wells Fargo
C Citi
$51.10 /

+0.79 (+1.57%)

06/09/20 Standpoint Research
Citi downgraded to Hold from Buy at Standpoint Research
06/05/20 Wells Fargo
Citi price target raised to $72 from $60 at Wells Fargo
06/05/20 Wells Fargo
Bank of America price target raised to $35 from $30 at Wells Fargo
06/02/20 Odeon Capital
Citi upgraded to Buy from Hold at Odeon Capital
HRC Hill-Rom
$109.92 /

+1.71 (+1.58%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
UNP Union Pacific
$169.21 /

+3.73 (+2.25%)

06/25/20 Benchmark
Union Pacific price target raised to $185 from $165 at Benchmark
06/03/20 BMO Capital
Union Pacific price target raised to $190 from $180 at BMO Capital
05/20/20 UBS
Union Pacific upgraded to Buy from Neutral at UBS
04/15/20 Wells Fargo
Union Pacific price target lowered to $155 from $200 at Wells Fargo
SPLK Splunk
$198.64 /

+4.26 (+2.19%)

06/29/20 Goldman Sachs
Splunk price target raised to $254 from $203 at Goldman Sachs
06/26/20 Berenberg
Splunk initiated with a Buy at Berenberg
06/22/20 Wells Fargo
Splunk price target raised to $250 from $205 at Wells Fargo
05/26/20 Argus
Splunk price target raised to $215 from $156 at Argus
QCOM Qualcomm
$91.21 /

+2.1 (+2.36%)

06/16/20
Fly Intel: Top five analyst upgrades
06/16/20 Morgan Stanley
Qualcomm upgraded to Overweight on improving smartphone demand at Morgan Stanley
06/16/20 Morgan Stanley
Qualcomm upgraded to Overweight from Equal Weight at Morgan Stanley
06/12/20 Susquehanna
Qualcomm price target raised to $105 from $95 at Susquehanna
IMMU Immunomedics
$35.45 /

+1.205 (+3.52%)

06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
05/29/20 Piper Sandler
Immunomedics' sacituzumab activity remains consistent, says Piper Sandler
05/28/20 H.C. Wainwright
Immunomedics CEO change to not impact Trodelvy launch, says H.C. Wainwright
05/28/20 Piper Sandler
Immunomedics confident in execution despite CEO change, says Piper Sandler
NFLX Netflix
$454.96 /

+7.86 (+1.76%)

06/30/20 Cowen
Netflix price target raised to $535 from $485 at Cowen
06/23/20 JPMorgan
Netflix user growth implies upside to Q2 guidance, says JPMorgan
06/18/20 Imperial Capital
Netflix price target raised to $489 from $485 at Imperial Capital
06/17/20 Jefferies
Jefferies says survey supports international pricing power for Netflix
CHTR Charter
$509.92 /

+1.43 (+0.28%)

06/26/20 Nomura Instinet
Comcast 'green shoots' are emerging, says Nomura Instinet
05/08/20 Benchmark
Charter price target raised to $600 from $523 at Benchmark
05/04/20 JPMorgan
Charter price target raised to $575 from $550 at JPMorgan
05/04/20 KeyBanc
Charter price target raised to $604 from $576 at KeyBanc
ATVI Activision Blizzard
$75.89 /

+0.43 (+0.57%)

06/29/20 Benchmark
Activision Blizzard price target raised to $85 from $77 at Benchmark
06/15/20 Stephens
Electronic Arts seems like best fit as buyer for WB Interactive, says Stephens
06/15/20 Oppenheimer
EA makes 'most sense' as potential buyer of Warner gaming unit, says Oppenheimer
06/02/20 Piper Sandler
Activision best positioned for second half of 2020, says Piper Sandler
EQIX Equinix
$701.53 /

+14.1 (+2.05%)

06/05/20 Deutsche Bank
Equinix resumed with a Buy at Deutsche Bank
05/13/20 RBC Capital
Equinix price target raised to $706 from $688 at RBC Capital
05/07/20 Wells Fargo
Equinix price target raised to $745 from $675 at Wells Fargo
05/07/20 JPMorgan
Equinix price target raised to $725 from $675 at JPMorgan
FANG Diamondback Energy
$41.82 /

+0.38 (+0.92%)

06/29/20 BMO Capital
Diamondback Energy downgraded to Market Perform from Outperform at BMO Capital
06/25/20
Diamondback Energy upgraded to Buy at SunTrust on improved cash flow outlook
06/25/20 SunTrust
Diamondback Energy upgraded to Buy from Hold at SunTrust
06/22/20 Goldman Sachs
Diamondback Energy downgraded to Neutral from Buy at Goldman Sachs
ALSN Allison Transmission
$36.78 /

-0.055 (-0.15%)

06/17/20 JPMorgan
North America Class 8 retail sales down 61% in May, says JPMorgan
05/07/20 Longbow
Navistar likely to beat near-term expectations, says Longbow
04/20/20 Citi
Allison Transmission downgraded to Neutral from Buy at Citi
04/20/20 Citi
Paccar upgraded to Buy from Neutral at Citi
MDLZ Mondelez
$51.12 /

+0.53 (+1.05%)

06/15/20
Fly Intel: Top five analyst upgrades
06/15/20 Berenberg
Mondelez upgraded to Buy from Hold at Berenberg
06/02/20 Morgan Stanley
Mondelez building momentum in U.S. and Europe, says Morgan Stanley
04/20/20 Morgan Stanley
Campbell Soup initiated with an Equal Weight at Morgan Stanley
SMG Scotts Miracle-Gro
$134.50 /

+4.66 (+3.59%)

06/02/20 Cleveland Research
Scotts Miracle-Gro in position to raise FY20 guidance, says Cleveland Research
05/26/20
Fly Intel: Top five analyst downgrades
05/26/20 Raymond James
Scotts Miracle-Gro double downgraded to Market Perform Raymond James
05/26/20 Raymond James
Scotts Miracle-Gro downgraded to Market Perform from Strong Buy at Raymond James
UNP Union Pacific
$169.21 /

+3.73 (+2.25%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SPLK Splunk
$198.64 /

+4.26 (+2.19%)

SMG Scotts Miracle-Gro
$134.50 /

+4.66 (+3.59%)

QCOM Qualcomm
$91.21 /

+2.1 (+2.36%)

NFLX Netflix
$454.96 /

+7.86 (+1.76%)

MDLZ Mondelez
$51.12 /

+0.53 (+1.05%)

LB L Brands
$15.00 /

-0.12 (-0.79%)

IMMU Immunomedics
$35.45 /

+1.205 (+3.52%)

HRC Hill-Rom
$109.92 /

+1.71 (+1.58%)

HLT Hilton
$73.44 /

-0.42 (-0.57%)

FANG Diamondback Energy
$41.82 /

+0.38 (+0.92%)

EQIX Equinix
$701.53 /

+14.1 (+2.05%)

CHTR Charter
$509.92 /

+1.43 (+0.28%)

C Citi
$51.10 /

+0.79 (+1.57%)

ATVI Activision Blizzard
$75.89 /

+0.43 (+0.57%)

ALSN Allison Transmission
$36.78 /

-0.055 (-0.15%)

ACGL Arch Capital
$28.68 /

+0.31 (+1.09%)

  • 12
    May
  • 29
    Apr
  • 05
    Dec
  • 31
    Jul
STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

QCOM Qualcomm
$91.21 /

+2.1 (+2.36%)

NFLX Netflix
$454.96 /

+7.86 (+1.76%)

MDLZ Mondelez
$51.12 /

+0.53 (+1.05%)

LB L Brands
$15.00 /

-0.12 (-0.79%)

IMMU Immunomedics
$35.45 /

+1.205 (+3.52%)

HLT Hilton
$73.44 /

-0.42 (-0.57%)

FANG Diamondback Energy
$41.82 /

+0.38 (+0.92%)

EQIX Equinix
$701.53 /

+14.1 (+2.05%)

CHTR Charter
$509.92 /

+1.43 (+0.28%)

C Citi
$51.10 /

+0.79 (+1.57%)

ATVI Activision Blizzard
$75.89 /

+0.43 (+0.57%)

UNP Union Pacific
$169.21 /

+3.73 (+2.25%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SPLK Splunk
$198.64 /

+4.26 (+2.19%)

SMG Scotts Miracle-Gro
$134.50 /

+4.66 (+3.59%)

QCOM Qualcomm
$91.21 /

+2.1 (+2.36%)

NFLX Netflix
$454.96 /

+7.86 (+1.76%)

MDLZ Mondelez
$51.12 /

+0.53 (+1.05%)

LB L Brands
$15.00 /

-0.12 (-0.79%)

IMMU Immunomedics
$35.45 /

+1.205 (+3.52%)

HLT Hilton
$73.44 /

-0.42 (-0.57%)

FANG Diamondback Energy
$41.82 /

+0.38 (+0.92%)

CHTR Charter
$509.92 /

+1.43 (+0.28%)

C Citi
$51.10 /

+0.79 (+1.57%)

ATVI Activision Blizzard
$75.89 /

+0.43 (+0.57%)

UNP Union Pacific
$169.21 /

+3.73 (+2.25%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SPLK Splunk
$198.64 /

+4.26 (+2.19%)

QCOM Qualcomm
$91.21 /

+2.1 (+2.36%)

NFLX Netflix
$454.96 /

+7.86 (+1.76%)

MDLZ Mondelez
$51.12 /

+0.53 (+1.05%)

LB L Brands
$15.00 /

-0.12 (-0.79%)

IMMU Immunomedics
$35.45 /

+1.205 (+3.52%)

HLT Hilton
$73.44 /

-0.42 (-0.57%)

FANG Diamondback Energy
$41.82 /

+0.38 (+0.92%)

EQIX Equinix
$701.53 /

+14.1 (+2.05%)

C Citi
$51.10 /

+0.79 (+1.57%)

ATVI Activision Blizzard
$75.89 /

+0.43 (+0.57%)

NFLX Netflix
$454.96 /

+7.86 (+1.76%)

C Citi
$51.10 /

+0.79 (+1.57%)

Over a month ago
Conference/Events
UBS to hold a virtual conference » 04:55
05/20/20
05/20
04:55
05/20/20
04:55
RDHL

RedHill Biopharma

$7.19 /

+0.28 (+4.05%)

, ANGO

AngioDynamics

$11.05 /

+0.11 (+1.01%)

, CDXS

Codexis

$11.15 /

-0.42 (-3.63%)

, AHCO

AdaptHealth

$16.68 /

+0.18 (+1.09%)

, APLT

Applied Therapeutics

$47.53 /

+2.41 (+5.34%)

, TFX

Teleflex

$346.33 /

-6.665 (-1.89%)

, UHS

Universal Health

$101.01 /

+0.55 (+0.55%)

, HRC

Hill-Rom

$98.94 /

-2.17 (-2.15%)

, NVRO

Nevro

$122.31 /

+0.47 (+0.39%)

, AMED

Amedisys

$190.01 /

-2.98 (-1.54%)

, ESTA

Establishment Labs

$16.25 /

-0.86 (-5.03%)

, HUM

Humana

$395.51 /

+4.41 (+1.13%)

, VKTX

Viking Therapeutics

$7.05 /

-0.09 (-1.26%)

, WST

West Pharmaceutical

$211.46 /

-7.14 (-3.27%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

TFX Teleflex
$346.33 /

-6.665 (-1.89%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

CDXS Codexis
$11.15 /

-0.42 (-3.63%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

AMED Amedisys
$190.01 /

-2.98 (-1.54%)

AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.15 /

-0.42 (-3.63%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$346.33 /

-6.665 (-1.89%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$101.01 /

+0.55 (+0.55%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$122.31 /

+0.47 (+0.39%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$190.01 /

-2.98 (-1.54%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$395.51 /

+4.41 (+1.13%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$211.46 /

-7.14 (-3.27%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

TFX Teleflex
$346.33 /

-6.665 (-1.89%)

RDHL RedHill Biopharma
$7.19 /

+0.28 (+4.05%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

HRC Hill-Rom
$98.94 /

-2.17 (-2.15%)

ESTA Establishment Labs
$16.25 /

-0.86 (-5.03%)

CDXS Codexis
$11.15 /

-0.42 (-3.63%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

AMED Amedisys
$190.01 /

-2.98 (-1.54%)

AHCO AdaptHealth
$16.68 /

+0.18 (+1.09%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

UHS Universal Health
$101.01 /

+0.55 (+0.55%)

NVRO Nevro
$122.31 /

+0.47 (+0.39%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

APLT Applied Therapeutics
$47.53 /

+2.41 (+5.34%)

ANGO AngioDynamics
$11.05 /

+0.11 (+1.01%)

VKTX Viking Therapeutics
$7.05 /

-0.09 (-1.26%)

HUM Humana
$395.51 /

+4.41 (+1.13%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/19/20
05/19
04:55
05/19/20
04:55
RDHL

RedHill Biopharma

$6.91 /

+0.18 (+2.67%)

, ANGO

AngioDynamics

$10.94 /

+0.93 (+9.29%)

, CDXS

Codexis

$11.57 /

+0.47 (+4.23%)

, AHCO

AdaptHealth

$16.50 /

+0.21 (+1.29%)

, APLT

Applied Therapeutics

$45.12 /

+1.22 (+2.78%)

, TFX

Teleflex

$353.00 /

+18.395 (+5.50%)

, UHS

Universal Health

$100.46 /

+7.86 (+8.49%)

, HRC

Hill-Rom

$101.11 /

+1.3 (+1.30%)

, NVRO

Nevro

$121.84 /

+4.09 (+3.47%)

, AMED

Amedisys

$192.99 /

+8.12 (+4.39%)

, ESTA

Establishment Labs

$17.11 /

+0.71 (+4.33%)

, HUM

Humana

$391.10 /

-7.25 (-1.82%)

, VKTX

Viking Therapeutics

$7.14 /

+0.04 (+0.56%)

, WST

West Pharmaceutical

$218.60 /

+4.73 (+2.21%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

TFX Teleflex
$353.00 /

+18.395 (+5.50%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

CDXS Codexis
$11.57 /

+0.47 (+4.23%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

AMED Amedisys
$192.99 /

+8.12 (+4.39%)

AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.57 /

+0.47 (+4.23%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$353.00 /

+18.395 (+5.50%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$100.46 /

+7.86 (+8.49%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$121.84 /

+4.09 (+3.47%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$192.99 /

+8.12 (+4.39%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$391.10 /

-7.25 (-1.82%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$218.60 /

+4.73 (+2.21%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

TFX Teleflex
$353.00 /

+18.395 (+5.50%)

RDHL RedHill Biopharma
$6.91 /

+0.18 (+2.67%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

HRC Hill-Rom
$101.11 /

+1.3 (+1.30%)

ESTA Establishment Labs
$17.11 /

+0.71 (+4.33%)

CDXS Codexis
$11.57 /

+0.47 (+4.23%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

AMED Amedisys
$192.99 /

+8.12 (+4.39%)

AHCO AdaptHealth
$16.50 /

+0.21 (+1.29%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

UHS Universal Health
$100.46 /

+7.86 (+8.49%)

NVRO Nevro
$121.84 /

+4.09 (+3.47%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

APLT Applied Therapeutics
$45.12 /

+1.22 (+2.78%)

ANGO AngioDynamics
$10.94 /

+0.93 (+9.29%)

VKTX Viking Therapeutics
$7.14 /

+0.04 (+0.56%)

HUM Humana
$391.10 /

-7.25 (-1.82%)

Conference/Events
UBS to hold a virtual conference » 08:53
05/18/20
05/18
08:53
05/18/20
08:53
RDHL

RedHill Biopharma

$6.73 /

-0.11 (-1.61%)

, ANGO

AngioDynamics

$10.01 /

+0.01 (+0.10%)

, CDXS

Codexis

$11.10 /

+0.35 (+3.26%)

, AHCO

AdaptHealth

$16.29 /

-0.11 (-0.67%)

, APLT

Applied Therapeutics

$43.90 /

+0.85 (+1.97%)

, TFX

Teleflex

$334.60 /

+1.41 (+0.42%)

, UHS

Universal Health

$92.60 /

+1.13 (+1.24%)

, HRC

Hill-Rom

$99.81 /

+0.4 (+0.40%)

, NVRO

Nevro

$117.75 /

-2.27 (-1.89%)

, AMED

Amedisys

$184.87 /

+7.66 (+4.32%)

, ESTA

Establishment Labs

$16.40 /

-0.91 (-5.26%)

, HUM

Humana

$398.35 /

+12.43 (+3.22%)

, VKTX

Viking Therapeutics

$7.10 /

+0.2 (+2.90%)

, WST

West Pharmaceutical

$213.87 /

+3.45 (+1.64%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference will be held on May 18-20.

ShowHide Related Items >><<
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

TFX Teleflex
$334.60 /

+1.41 (+0.42%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

CDXS Codexis
$11.10 /

+0.35 (+3.26%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
CDXS Codexis
$11.10 /

+0.35 (+3.26%)

03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

02/28/20 Deutsche Bank
AdaptHealth price target raised to $19 from $12 at Deutsche Bank
01/31/20
Fly Intel: Top five analyst initiations
01/30/20 Stifel
AdaptHealth initiated with a Buy at Stifel
01/07/20 Jefferies
Jefferies starts AdaptHealth at Buy with $15 price target
APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
TFX Teleflex
$334.60 /

+1.41 (+0.42%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
UHS Universal Health
$92.60 /

+1.13 (+1.24%)

04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
04/28/20 Citi
Universal Health price target lowered to $128 from $157 at Citi
03/26/20 JPMorgan
Channel checks suggest hospital total revenues down 40%-60%, says JPMorgan
03/23/20 BofA
Universal Health downgraded to Neutral on Vegas recession risk at BofA
HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
NVRO Nevro
$117.75 /

-2.27 (-1.89%)

05/06/20 Citi
Nevro price target raised to $137 from $130 at Citi
04/02/20 SunTrust
Nevro price target lowered to $120 from $146 at SunTrust
04/02/20 Wells Fargo
Nevro price target lowered to $126 from $158 at Wells Fargo
03/04/20 Citi
Nevro initiated with a Buy at Citi
AMED Amedisys
$184.87 /

+7.66 (+4.32%)

05/11/20 Raymond James
Amedisys price target lowered to $210 from $225 at Raymond James
05/07/20 Benchmark
Amedisys downgraded to Hold on limited near-term visibility at Benchmark
05/07/20 Benchmark
Amedisys downgraded to Hold from Buy at Benchmark
03/09/20 Benchmark
Benchmark upgrades Amedisys to Buy on Home Health boost from crowded hospitals
ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HUM Humana
$398.35 /

+12.43 (+3.22%)

05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
04/29/20 Cantor Fitzgerald
Humana comments on telephonic sales 'positive' for eHealth, says Cantor
VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

05/05/20 Chardan
Viking Therapeutics initiated with a Buy at Chardan
05/04/20 B. Riley FBR
Viking Therapeutics price target lowered to $12 from $16 at B. Riley FBR
05/01/20 BTIG
Viking Therapeutics initiated with a Buy at BTIG
02/27/20 H.C. Wainwright
Viking Therapeutics price target lowered to $18 from $31 at H.C. Wainwright
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
04/24/20 BofA
West Pharmaceutical upgraded to Neutral from Underperform at BofA
12/12/19
Fly Intel: Top five analyst downgrades
12/12/19 BofA
West Pharmaceutical downgraded to Underperform from Neutral at BofA/Merrill
WST West Pharmaceutical
$213.87 /

+3.45 (+1.64%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

TFX Teleflex
$334.60 /

+1.41 (+0.42%)

RDHL RedHill Biopharma
$6.73 /

-0.11 (-1.61%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

HRC Hill-Rom
$99.81 /

+0.4 (+0.40%)

ESTA Establishment Labs
$16.40 /

-0.91 (-5.26%)

CDXS Codexis
$11.10 /

+0.35 (+3.26%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

AHCO AdaptHealth
$16.29 /

-0.11 (-0.67%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

UHS Universal Health
$92.60 /

+1.13 (+1.24%)

NVRO Nevro
$117.75 /

-2.27 (-1.89%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

APLT Applied Therapeutics
$43.90 /

+0.85 (+1.97%)

ANGO AngioDynamics
$10.01 /

+0.01 (+0.10%)

AMED Amedisys
$184.87 /

+7.66 (+4.32%)

VKTX Viking Therapeutics
$7.10 /

+0.2 (+2.90%)

HUM Humana
$398.35 /

+12.43 (+3.22%)

Hot Stocks
Hill-Rom announces initiatives in response to COVID-19 pandemic » 07:05
05/01/20
05/01
07:05
05/01/20
07:05
HRC

Hill-Rom

$113.05 /

-1.8 (-1.57%)

The company said,…

The company said, "Hillrom is committed to mobilizing its resources and supporting customers, caregivers and patients with decisive actions in the global response to COVID-19, including the following initiatives: Pivoting R&D efforts to introduce several innovative solutions in response to the surge in COVID-19 treatment challenges. Accomplishments include: Receiving U.S. Food and Drug Administration Emergency Use Authorization for a new closed-circuit design using a bacterial-viral filter for oscillation and lung expansion therapy with the MetaNeb(R) System to reduce cross contamination from escaped aerosolized particles. Adding a new feature to the Connex(R) Vital Signs Monitor to digitally capture a patient's respiratory rate; and including a remote monitoring platform to simplify connectivity to the recently launched Welch Allyn(R) Spot(R) 4400 Vital Signs Monitor, allowing clinicians to remotely receive a complete set of vitals, including SPO2, temperature and blood pressure. Launching a remote mobile software solution, Voalte Extend(TM), to respond to customers' emergent needs to connect patients and caregivers from a mobile device in makeshift care areas while limiting unnecessary exposure. Partnering with AgileMD, a developer of EHR-integrated web and mobile applications for point-of-care use, to offer a digital COVID-19 solution, including clinical pathways and predictive analytics through an EHR-integrated software platform. Adapting Hillrom patient positioning equipment for use in the ICU and med-surg environments to offer clinically proven prone movement and positioning capabilities for both ventilated and non-ventilated patients. Prone positioning is emerging as an important strategy in the treatment and survival rates of COVID-19 patients. Ramping up production with the goal of increasing capacity of the Life2000 non-invasive ventilator five-fold on an annualized basis, and more than doubling production of other critical care products, including ICU and med-surg hospital beds, patient monitoring devices, and physical assessment tools and consumables to meet increased demand. With these efforts, Hillrom is adding more than 300 permanent and temporary positions to its global workforce. Working collaboratively with the U.S. Department of Health and Human Services and Federal Emergency Management Agency to supply at least 3,400 Life2000 non-invasive ventilators. Executing business continuity plans and working with global supply chain partners to successfully meet customer demand, while minimizing the potential for manufacturing or supply chain disruption. Implementing a comprehensive global action plan, including proactive measures to protect employees' health and safety while providing front-line support to healthcare providers and ensuring products are available when and where customers and patients need them. Supporting global COVID-19 relief efforts by contributing approximately $6 million through both monetary and critical medical product donations."

ShowHide Related Items >><<
HRC Hill-Rom
$113.05 /

-1.8 (-1.57%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
Earnings
Hill-Rom reports Q2 adj. EPS $1.28, consensus $1.15 » 07:02
05/01/20
05/01
07:02
05/01/20
07:02
HRC

Hill-Rom

$113.05 /

-1.8 (-1.57%)

Reports Q2 revenue…

Reports Q2 revenue $723.2M, consensus $701.64M. "During this unprecedented and challenging period, Hillrom's mission of enhancing outcomes for patients and caregivers has never been more vital. I am extremely proud of the entire Hillrom organization, their dedication, and extraordinary contributions team members are making to support our customers as we fight this pandemic. We rapidly expanded production of critical care products, pivoted R&D efforts, and are now introducing a spectrum of new products to meet unique COVID-19 treatment challenges," said John Groetelaars, Hillrom president and CEO. "We remain confident in our ability to navigate this uncertain business and healthcare environment. The combination of our financial strength, diverse portfolio of innovative products, services and solutions, and exceptional execution, underscores our unwavering commitment to enhancing value for stakeholders."

ShowHide Related Items >><<
HRC Hill-Rom
$113.05 /

-1.8 (-1.57%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
Over a quarter ago
General News
Trump statement on order under the Defense Production Act to make ventilators » 17:09
04/02/20
04/02
17:09
04/02/20
17:09
GE

General Electric

$6.89 /

-0.15 (-2.13%)

, HRC

Hill-Rom

$108.09 /

+4.01 (+3.85%)

, MDT

Medtronic

$86.15 /

+2.06 (+2.45%)

, RMD

ResMed

$149.68 /

+7.52 (+5.29%)

"Today, I have…

"Today, I have issued an order under the Defense Production Act to more fully ensure that domestic manufacturers can produce ventilators needed to save American lives. My order to the Secretary of Health and Human Services and the Secretary of Homeland Security will help domestic manufacturers like General Electric, Hill-Rom, Medtronic, ResMed, Royal Philips, and Vyaire Medical secure the supplies they need to build ventilators needed to defeat the virus. I am grateful to these and other domestic manufacturers for ramping up their production of ventilators during this difficult time. Today's order will save lives by removing obstacles in the supply chain that threaten the rapid production of ventilators." Companies mentioned in the order include General Electric (GE), Hill-Rom (HRC), Medtronic (MDT) ResMed (RMD). Reference Link

ShowHide Related Items >><<
GE General Electric
$6.89 /

-0.15 (-2.13%)

03/31/20 JPMorgan
Rockwell, GE least favored Multi-Industry names at JPMorgan
03/27/20 Gabelli
GE CEO 'taking the right steps' in face of 'steeper hill to climb,' says Gabelli
03/05/20 Cowen
General Electric limited upside seen from current levels, says Cowen
03/03/20 Piper Sandler
Danaher unlikely to make competing bid for Qiagen, says Piper Sandler
HRC Hill-Rom
$108.09 /

+4.01 (+3.85%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
MDT Medtronic
$86.15 /

+2.06 (+2.45%)

03/30/20
Fly Intel: Top five analyst downgrades
03/30/20 BTIG
Medtronic price target lowered to $102 from $124 at BTIG
03/30/20 Needham
Medtronic downgraded to Buy from Strong Buy at Needham
03/30/20 Needham
Medtronic downgraded to Buy from Strong Buy at Needham
RMD ResMed
$149.68 /

+7.52 (+5.29%)

04/01/20 JPMorgan
ResMed 'a vent company too,' says JPMorgan
03/26/20 Credit Suisse
ResMed downgraded to Neutral from Outperform at Credit Suisse
02/18/20 Morgan Stanley
ResMed downgraded to Equal Weight on valuation at Morgan Stanley
02/18/20 Morgan Stanley
ResMed downgraded to Equal Weight from Overweight at Morgan Stanley
Hot Stocks
Hill-Rom announces growth in demand of several critical products » 16:14
03/24/20
03/24
16:14
03/24/20
16:14
HRC

Hill-Rom

$86.00 /

+11.07 (+14.77%)

Hillrom announced actions…

Hillrom announced actions it is taking to support customers and caregivers with critical care products necessary to meet COVID-19 patient needs. Hillrom's business operations continue with no material interruption as global demand for several critical products has grown substantially. The company is working to significantly ramp up production of these products, with the goal of more than doubling capacity in the following areas: respiratory health, especially Life2000; ICU and med-surg unit smart beds, patient monitoring and diagnostics, including the company's Connex and Spot Vital Signs monitors as well as physical assessment tools and consumables. The company has seen no material disruption in its supply chain to date. Hillrom's suppliers are a critical component of successfully meeting customer demand, and the company is working with its supply chain partners to minimize any potential disruption.

ShowHide Related Items >><<
HRC Hill-Rom
$86.00 /

+11.07 (+14.77%)

03/17/20 Barclays
Hill-Rom upgraded to Overweight from Equal Weight at Barclays
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
Upgrade
Hill-Rom upgraded to Overweight from Equal Weight at Barclays » 05:00
03/17/20
03/17
05:00
03/17/20
05:00
HRC

Hill-Rom

$80.92 /

-8.43 (-9.43%)

Barclays analyst Kristen…

Barclays analyst Kristen Stewart upgraded Hill-Rom Holdings to Overweight from Equal Weight with a $116 price target.

ShowHide Related Items >><<
HRC Hill-Rom
$80.92 /

-8.43 (-9.43%)

12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
Conference/Events
Barclays to hold a conference » 04:55
03/12/20
03/12
04:55
03/12/20
04:55
ABC

AmerisourceBergen

$84.90 /

-1.21 (-1.41%)

, AMAG

Amag Pharmaceuticals

$6.62 /

-0.64 (-8.82%)

, AZN

AstraZeneca

$44.57 /

-2.32 (-4.95%)

, AVNS

Avanos

$29.00 /

-3.11 (-9.69%)

, BDX

Becton Dickinson

$232.14 /

-5.18 (-2.18%)

, BIO

Bio-Rad

$345.64 /

-21.41 (-5.83%)

, CAH

Cardinal Health

$48.77 /

-0.94 (-1.89%)

, CLVS

Clovis

$6.16 /

-0.105 (-1.68%)

, COO

Cooper Companies

$323.96 /

-10.03 (-3.00%)

, CVS

CVS Health

$61.26 /

-1.36 (-2.17%)

, DGX

Quest Diagnostics

$99.75 /

-6.65 (-6.25%)

, EHTH

eHealth

$126.95 /

-6.99 (-5.22%)

, EXEL

Exelixis

$17.32 /

-1.09 (-5.92%)

, FATE

Fate Therapeutics

$23.79 /

-2.2 (-8.46%)

, FLDM

Fluidigm

$2.62 /

-0.27 (-9.34%)

, FMS

Fresenius Medical

$35.40 /

-2.24 (-5.95%)

, GRTS

Gritstone Oncology

$6.64 /

-0.39 (-5.55%)

, HRC

Hill-Rom

$89.24 /

-0.89 (-0.99%)

, HUM

Humana

$328.50 /

-20.52 (-5.88%)

, IMMU

Immunomedics

$13.38 /

-1.9 (-12.43%)

, IRWD

Ironwood

$10.49 /

-0.96 (-8.38%)

, ITGR

Integer

$79.28 /

-4.07 (-4.88%)

, JAZZ

Jazz Pharmaceuticals

$108.33 /

-4.42 (-3.92%)

, JNJ

Johnson & Johnson

$131.65 /

-10.05 (-7.09%)

, ZIOP

Ziopharm

$2.53 /

-0.24 (-8.68%)

, VNDA

Vanda Pharmaceuticals

$10.60 /

-0.2 (-1.85%)

, QGEN

Qiagen

$41.10 /

-0.33 (-0.80%)

, MRNA

Moderna

$23.61 /

+1.27 (+5.68%)

, MTD

Mettler-Toledo

$661.68 /

-35 (-5.02%)

, MTEM

Molecular Templates

$13.20 /

-1.48 (-10.08%)

, NTRA

Natera

$31.00 /

+0.07 (+0.23%)

, PODD

Insulet

$172.13 /

-8.29 (-4.59%)

, PTCT

PTC Therapeutics

$47.07 /

-4.23 (-8.25%)

Global Healthcare…

Global Healthcare Conference 2020 will be held in Miami on March 10-12.

ShowHide Related Items >><<
ABC AmerisourceBergen
$84.90 /

-1.21 (-1.41%)

02/07/20 Baird
AmerisourceBergen upgraded to Outperform at Baird
02/07/20 Baird
AmerisourceBergen upgraded to Outperform from Neutral at Baird
01/28/20 Cleveland Research
AmerisourceBergen appears to be gaining share, says Cleveland Research
10/16/19 Jefferies
Drug distributor settlement would make stocks 'ownable again,' says Jefferies
AMAG Amag Pharmaceuticals
$6.62 /

-0.64 (-8.82%)

03/04/20 Piper Sandler
Amag Pharmaceuticals price target lowered to $7 from $9 at Piper Sandler
03/03/20 H.C. Wainwright
Amag Pharmaceuticals price target lowered to $12 from $16 at H.C. Wainwright
01/09/20 Piper Sandler
Amag business still facing 'significant challenges,' says Piper Sandler
11/04/19 Barclays
Amag Pharmaceuticals price target lowered to $14 from $16 at Barclays
AZN AstraZeneca
$44.57 /

-2.32 (-4.95%)

02/28/20 Cowen
AstaZeneca pipeline leads to best European idea, says Cowen
01/27/20 William Blair
PhaseBio could see increase to PB2452 addressable market, says William Blair
01/22/20 Liberum
Sanofi downgraded to Hold from Buy at Liberum (earlier)
01/22/20 Oppenheimer
Amarin price target raised to $13 from $8 at Oppenheimer
AVNS Avanos
$29.00 /

-3.11 (-9.69%)

12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
11/06/19 Stifel
Avanos downgraded to Hold from Buy at Stifel
11/06/19 Stifel
Avanos downgraded to Hold from Buy at Stifel
11/06/19 Raymond James
Avanos shares could be range-bound over next six months, says Raymond James
BDX Becton Dickinson
$232.14 /

-5.18 (-2.18%)

03/04/20 Citi
Becton Dickinson initiated with a Neutral at Citi
03/02/20 Wells Fargo
Baxter, J&J best positioned to weather coronavirus spread, says Wells Fargo
02/07/20
Fly Intel: Top five analyst downgrades
02/07/20 Raymond James
Becton Dickinson downgraded at Raymond James given pump overhang
BIO Bio-Rad
$345.64 /

-21.41 (-5.83%)

03/03/20 Citi
Bio-Rad margin expansion story in early innings, says Citi
01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Bio-Rad initiated with an Overweight at Wells Fargo
01/06/20 Citi
Citi calls Bio-Rad, Thermo Fisher top picks in Tools industry
CAH Cardinal Health
$48.77 /

-0.94 (-1.89%)

02/12/20 Morgan Stanley
Cardinal Health upgraded to Equal Weight from Underweight at Morgan Stanley
02/07/20 Baird
Cardinal Health upgraded to Outperform at Baird
02/07/20 Mizuho
Cardinal Health price target raised to $58 from $52 at Mizuho
02/07/20 Baird
Cardinal Health upgraded to Outperform from Neutral at Baird
CLVS Clovis
$6.16 /

-0.105 (-1.68%)

02/25/20
Fly Intel: Top five analyst initiations
02/25/20 RBC Capital
Clovis initiated with an Outperform at RBC Capital
01/08/20 H.C. Wainwright
Clovis price target lowered to $27 from $36 at H.C. Wainwright
01/07/20 Piper Sandler
Clovis modestly extends cash runway with debt deal, says Piper Sandler
COO Cooper Companies
$323.96 /

-10.03 (-3.00%)

03/06/20 Baird
Cooper Companies price target raised to $357 from $345 at Baird
03/06/20 Piper Sandler
Cooper Companies price target raised to $351 from $344 at Piper Sandler
03/04/20 Citi
Cooper Companies initiated with a Neutral at Citi
CVS CVS Health
$61.26 /

-1.36 (-2.17%)

02/20/20 Stephens
Stephens watching near-term MCO stock reactions after Bloomberg's 'rough' debate
02/18/20 Deutsche Bank
Deutsche raises price targets in Managed Care on fading political risks
02/10/20 Cowen
CVS upside to guidance seen, says Cowen
01/21/20 Cantor Fitzgerald
CVS, Cigna and Centene a buy on any block grant selloff, says Cantor
DGX Quest Diagnostics
$99.75 /

-6.65 (-6.25%)

03/06/20 Jefferies
COVID-19 tests unlikely to move needle for Quest or LabCorp, says Jefferies
03/05/20 JPMorgan
Quest Diagnostics' COVID-19 testing to be small benefit for 2020, says JPMorgan
02/10/20 Mizuho
Quest Diagnostics price target raised to $122 from $116 at Mizuho
01/30/20 Piper Sandler
Quest Diagnostics price target raised to $107 from $102 at Piper Sandler
EHTH eHealth
$126.95 /

-6.99 (-5.22%)

02/24/20 Credit Suisse
eHealth price target raised to $179 from $145 at Credit Suisse
02/21/20 SunTrust
eHealth price target raised to $250 from $200 at SunTrust
02/21/20 Craig-Hallum
eHealth price target raised to $200 from $150 at Craig-Hallum
02/21/20 RBC Capital
eHealth price target raised to $166 from $132 at RBC Capital
EXEL Exelixis
$17.32 /

-1.09 (-5.92%)

03/04/20 Barclays
Barclays starts small, mid cap Biotechnology sector with Positive view
03/04/20 Barclays
Exelixis initiated with an Overweight at Barclays
02/27/20 Piper Sandler
Exelixis price target lowered to $23 from $35 at Piper Sandler
02/11/20 Piper Sandler
Exelixis data 'impressive,' support accelerated approval, says Piper Sandler
FATE Fate Therapeutics
$23.79 /

-2.2 (-8.46%)

03/04/20 Citi
Fate Therapeutics price target raised to $41 from $26 at Citi
03/04/20 Barclays
Fate Therapeutics initiated with an Overweight at Barclays
03/03/20 BMO Capital
Fate Therapeutics price target raised to $28 from $22 at BMO Capital
FLDM Fluidigm
$2.62 /

-0.27 (-9.34%)

02/11/20 Piper Sandler
Fluidigm price target lowered to $9 from $14 at Piper Sandler
01/14/20 Piper Sandler
Piper Sandler reiterates Overweight on Fluidigm after Q4 results, guidance
11/06/19 Janney Montgomery Scott
Fluidigm downgraded to Neutral after Q3 miss at Janney Montgomery Scott
11/06/19 Janney Montgomery Scott
Fluidigm downgraded to Neutral from Buy at Janney Montgomery Scott
FMS Fresenius Medical
$35.40 /

-2.24 (-5.95%)

03/05/20 Berenberg
Fresenius Medical price target lowered to EUR 89.70 from EUR 89.95 at Berenberg
01/21/20 Jefferies
Fresenius Medical upgraded to Buy from Hold at Jefferies
12/06/19 Morgan Stanley
Fresenius Medical downgraded to Underweight from Equal Weight at Morgan Stanley
10/23/19 Redburn
Redburn downgrades Fresenius Medical to Neutral on growth concerns
GRTS Gritstone Oncology
$6.64 /

-0.39 (-5.55%)

07/26/19
Fly Intel: Top five analyst initiations
07/25/19 Baird
Gritstone Oncology initiated with an Outperform at Baird
03/27/19 Berenberg
Gritstone Oncology initiated with a Buy at Berenberg
03/14/19 Raymond James
Gritstone Oncology initiated with an Outperform at Raymond James
HRC Hill-Rom
$89.24 /

-0.89 (-0.99%)

12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight on accelerating momentum at Morgan Stanley
12/17/19 Morgan Stanley
Hill-Rom upgraded to Overweight from Equal Weight at Morgan Stanley
06/27/19 Raymond James
Hill-Rom's DoD contract win a 'nice development,' says Raymond James
HUM Humana
$328.50 /

-20.52 (-5.88%)

01/23/20 UBS
Humana price target raised to $406 from $321 at UBS
01/08/20 Credit Suisse
Humana price target raised to $400 from $378 at Credit Suisse
IMMU Immunomedics
$13.38 /

-1.9 (-12.43%)

02/24/20 Jefferies
Epizyme, Blueprint among cancer companies that fit M&A criteria, says Jefferies
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/27/19 H.C. Wainwright
Immunomedics price target raised to $31 from $26 at H.C. Wainwright
12/20/19 BofA
Immunomedics initiated with a Buy at BofA/Merrill
IRWD Ironwood
$10.49 /

-0.96 (-8.38%)

08/05/19 Credit Suisse
Ironwood assumed with a Neutral at Credit Suisse
07/10/19 Credit Suisse
Ironwood assumed with a Neutral at Credit Suisse
03/27/19 Morgan Stanley
Morgan Stanley upgrades Ironwood to Equal Weight on more stable Linzess growth
03/27/19 Morgan Stanley
Ironwood upgraded to Equal Weight from Underweight at Morgan Stanley
ITGR Integer
$79.28 /

-4.07 (-4.88%)

06/05/19 Argus
Integer price target lowered to $90 from $103 at Argus
JAZZ Jazz Pharmaceuticals
$108.33 /

-4.42 (-3.92%)

02/26/20 RBC Capital
Jazz Pharmaceuticals price target lowered to $164 from $184 at RBC Capital
02/26/20 Oppenheimer
Jazz Pharmaceuticals price target lowered to $154 from $183 at Oppenheimer
02/26/20 Cowen
Jazz Pharmaceuticals lowered his price target to $165 from $200 at Cowen
02/26/20 Piper Sandler
Jazz Pharmaceuticals price target lowered to $129 from $142 at Piper Sandler
JNJ Johnson & Johnson
$131.65 /

-10.05 (-7.09%)

03/11/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Genmab following J&J drug announcement
03/06/20 Credit Suisse
Johnson & Johnson price target lowered to $159 from $170 at Credit Suisse
03/04/20 Citi
Johnson & Johnson initiated with a Buy at Citi
ZIOP Ziopharm
$2.53 /

-0.24 (-8.68%)

03/04/20
Fly Intel: Top five analyst initiations
03/04/20 Cantor Fitzgerald
Ziopharm initiated with Overweight, $6 price target at Cantor Fitzgerald
03/03/20 Cantor Fitzgerald
Ziopharm initiated with an Overweight at Cantor Fitzgerald
08/23/19
Fly Intel: Top five analyst initiations
VNDA Vanda Pharmaceuticals
$10.60 /

-0.2 (-1.85%)

03/12/20 Citi
Vanda Pharmaceuticals upgraded to Buy from Neutral at Citi
02/27/20 Oppenheimer
Vanda Pharmaceuticals price target lowered to $12 from $18 at Oppenheimer
02/26/20 JMP Securities
Vanda Pharmaceuticals price target lowered to $25 from $52 at JMP Securities
11/07/19 Citi
Citi downgrades Vanda to Neutral after 'excessive' post-earnings rally
QGEN Qiagen
$41.10 /

-0.33 (-0.80%)

03/04/20 Stifel
Qiagen deal a positive for Thermo Fisher, says Stifel
03/04/20 Berenberg
Qiagen downgraded to Hold from Buy at Berenberg
03/03/20 Piper Sandler
Danaher unlikely to make competing bid for Qiagen, says Piper Sandler
02/05/20 Piper Sandler
Qiagen price target raised to $36 from $29 at Piper Sandler
MRNA Moderna
$23.61 /

+1.27 (+5.68%)

03/05/20
Fly Intel: Top five analyst downgrades
03/05/20 BofA
Moderna downgraded to Neutral from Buy at BofA
03/05/20 BofA
Moderna downgraded to Neutral from Buy at BofA
03/04/20 Piper Sandler
Moderna's Manufacturing & Digital Day showcases its mRNA advantages, says Piper
MTD Mettler-Toledo
$661.68 /

-35 (-5.02%)

02/07/20 UBS
Mettler-Toledo upgraded to Neutral from Sell at UBS
01/07/20 Wells Fargo
Mettler-Toledo initiated with an Equal Weight at Wells Fargo
01/06/20 Citi
Mettler-Toledo initiated with a Neutral at Citi
01/02/20 Evercore ISI
Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
MTEM Molecular Templates
$13.20 /

-1.48 (-10.08%)

02/27/20 Barclays
Molecular Templates initiated with an Overweight at Barclays
02/27/20 Barclays
Molecular Templates initiated with an Overweight at Barclays
04/29/19 UBS
Molecular Templates initiated with a Buy at UBS
NTRA Natera
$31.00 /

+0.07 (+0.23%)

02/27/20 Piper Sandler
Natera price target raised to $49 from $45 at Piper Sandler
12/19/19 Craig-Hallum
Natera kidney test to be covered under Medicare in February, says Craig-Hallum
12/19/19 Piper Sandler
CareDx should be bought on weakness from Natera coverage, says Piper
11/11/19 Canaccord
Natera results solid, remains a top pick at Canaccord
PODD Insulet
$172.13 /

-8.29 (-4.59%)

03/04/20 Citi
Insulet initiated with a Buy at Citi
03/02/20 Piper Sandler
Insulet should be bought on selloff from trial delay, says Piper Sandler
02/26/20 Cowen
Insulet weakness a buying opportunity, says Cowen
02/26/20 Raymond James
Insulet price target lowered to $205 from $213 at Raymond James
PTCT PTC Therapeutics
$47.07 /

-4.23 (-8.25%)

03/03/20 Cantor Fitzgerald
PTC Therapeutics price target raised to $86 from $81 at Cantor Fitzgerald
02/20/20 RBC Capital
PTC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
02/20/20 Citi
PTC Therapeutics downgraded to Neutral from Buy at Citi
02/20/20 RBC Capital
PTC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.